TNTim Nuttall

Tim Nuttall

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tim Nuttall has a total of 126 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Benchmarking nanopore-based strategies for antimicrobial resistance prediction

    by Natalie Ring, Alison S. Low, Rhodri Evans, Marianne Keith, Gavin K. Paterson, David Gally, Tim Nuttall, Dylan Neil Clements, J. Ross Fitzgerald

    Antimicrobial resistance (AMR) presents a pressing need to ensure that the right antimicrobials are used to target the right microbes at the right time. Ideally, the appropriate antimicrobial is selected after patient samples have been cultured and assessed with antimicrobial sensitivity testing (AST). However, the time needed for culture-based diagnosis leads to immediate empirical treatment, often with broad-spectrum and/or high-tier antimicrobials. Direct nanopore metagenomic whole-genome sequencing to identify pathogens and predict their AMR is a rapid and patient-side alternative. A limitation of this approach is potential inconsistencies in i predicted AMR phenotypes. Here, we benchmarked the current performance of in silico AMR prediction strategies for nanopore-generated long-read data. Using real-world nanopore data paired with AST phenotyping for 201 samples representing 27 bacterial species, we assessed the impact of basecalling mode, data volume and assembly strategy and compared the performance of eight in silico AMR prediction tools with seven AMR databases. We found that basecalling accuracy mode does not significantly affect the overall accuracy of in silico AMR predictions but assembly strategy and data volume both do. Prediction tools using the ResFinder database scored best for balanced accuracy (0.80±0.02 for both ResFinder and ABRicate), whilst DeepARG scored best for sensitivity (0.65±0.03); predictions were more accurate for some antibiotic classes and genera than others. However, even the best-performing in silico AMR prediction strategy missed some resistance identified by lab-based AST. We conclude, therefore, that currently in silico AMR prediction can supplement lab-based AST but cannot yet replace it.

  • Open Access

    Medial Tympanic Membrane Displacement in Five Dogs Resembling Tympanic Membrane Retraction in Humans

    by Cristiane Bazaga Botelho, Tássia Sell Ferreira, Vanessa Cunningham Gmyterco, Caroline Alves, Tim Nuttall, Marconi Rodrigues de Farias, Júlio Israel Fernandes

    Five dogs with head tilt, ataxia, incoordination or deafness without a history of otitis externa (OE) were diagnosed with otitis media by computed tomography (CT) or magnetic resonance imaging (MRI). Otoendoscopy showed possible tympanic membrane retraction with opaque, fibrotic membranes and advanced imaging showed middle ear involvement. The clinical significance requires further investigation.

  • Open Access

    Treatment of Canine Atopic Dermatitis: Updated Guidelines From the International Committee on Allergic Diseases of Animals ( ICADA )

    by Ralf S. Mueller, Frane Banovic, Emmanuel Bensignor, Domenico Santoro, Tim Nuttall

    Background: Canine atopic dermatitis (cAD) is a genetically, aetiologically, immunologically and clinically complex disease requiring both individualised immediate and long‐term management. Objectives: These updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA) aim to substantially revise previous recommendations by organising treatment according to mechanism‐of‐action and by distinguishing two therapeutic phases: reactive therapy to resolve existing pruritus and skin lesions, followed by proactive therapy to maintain remission and reduce flares. Materials and Methods: The literature was reviewed and recommendations are based, where possible, on randomised controlled trials and systematic reviews, with evidence graded using the Strength of Recommendation Taxonomy. The guidelines review skin barrier care, antimicrobial and microbiome‐modulating interventions, avoidance of nonallergenic and allergenic flare factors, allergen‐specific immunotherapy, and anti‐inflammatory, antipruritic and immunomodulatory treatments. Results: Rapid‐acting broad‐spectrum drugs, particularly glucocorticoids, are recommended for reactive treatment. Janus Kinase (JAK) inhibitors and lokivetmab may be effective depending on lesion type, severity and inflammatory complexity. Secondary infections and flare factors must be addressed. Proactive management essential to prevent repeated cycles of inflammation may include skin barrier support, infection control, allergen avoidance, allergen immunotherapy, topical glucocorticoids, ciclosporin, tacrolimus, lokivetmab or JAK inhibitors, selected according to the patient's disease pattern and response. Conclusions and Clinical Relevance: A number of interventions are suitable for the treatment of cAD. Interventions are neither universally required, interchangeable nor effective in all cases. Treatment selection should take into account efficacy, safety, practicality, cost, the quality‐of‐life of both dog and owner, and the legal regulations applicable in the country of use.


  • Open Access

    Faecal IgA but not salivary IgA is associated with canine atopic dermatitis

    by A. Campbell, T. Nuttall, V. Robinson, F. Soutter

    Objectives: To characterise immunoglobulin A (IgA) levels in the faeces and saliva of dogs with canine atopic dermatitis (CAD) and healthy breed matched controls. Materials and Methods: Dogs with canine atopic dermatitis were recruited based on history, clinical examination and diagnostic testing where appropriate. Control dogs were over 4 years of age with no history of skin disease. Saliva samples were obtained using chewable synthetic swabs with saliva extracted by centrifugation. Faecal samples were collected from the ground before homogenisation in phosphate buffered saline and centrifugation to extract faecal supernatant. Total immunoglobulin A in saliva and faecal supernatants was measured using a commercial dog immunoglobulin A ELISA kit. Immunoglobulin A concentration was interpolated from a six‐point standard curve. Mann–Whitney tests were performed to compare immunoglobulin A concentrations between cases and controls. Results: Mean ranked faecal immunoglobulin A was significantly lower in dogs with canine atopic dermatitis than controls (difference between medians 0.803 g/L, 95% CI 0.064 to 1.721). There was no significant difference in mean ranked salivary immunoglobulin A between the groups (difference between medians 0.108 g/L). Faecal immunoglobulin A and salivary immunoglobulin A were not correlated. There were no dogs in either group with both low faecal and low salivary immunoglobulin A suggestive of selective immunoglobulin A deficiency. Clinical Significance: This study builds on existing evidence that low immunoglobulin A is associated with canine atopic dermatitis. Further work is required to determine the significance of low faecal immunoglobulin A in the development of tolerance or hypersensitivity to food and environmental allergens which may inform strategies for interventions in high‐risk breeds.

  • Open Access

    A systematic comparison of tools for predicting antimicrobial resistance from nanopore sequence data

    by Natalie Ring, Alison S Low, Rhodri Evans, Marianne Keith, Gavin K. Paterson, David Gally, Tim Nuttall, Dylan Neil Clements, J. Ross Fitzgerald

    Antimicrobial resistance (AMR) presents a pressing need to ensure that the right antimicrobials are used to target the right microbes at the right time. Ideally, the appropriate antimicrobial is selected after patient samples have been cultured and assessed with antimicrobial sensitivity testing (AST). However, the time needed for culture-based diagnosis leads to immediate empirical treatment, often with broad-spectrum and/or high-tier antimicrobials. Direct nanopore metagenomic whole genome sequencing to identify the pathogens and predict their antimicrobial resistance is a rapid and patient-side alternative. A limitation of this approach is the inconsistency of in silico predicted AMR phenotypes. Here, we benchmarked the current performance of in silico AMR prediction strategies for nanopore-generated long read data. Using nanopore data paired with AST phenotyping for 201 samples, we assessed the impact of basecalling mode, data volume, and assembly strategy to compare the performance of eight in silico AMR prediction tools with seven AMR databases. We found that basecalling accuracy mode does not affect the overall accuracy of in silico AMR predictions, but assembly strategy and data volume both do. Prediction tools using the ResFinder database scored best for balanced accuracy (0.8 for both ResFinder and ABRicate), whilst DeepARG scored best for sensitivity (0.65). However, even the best performing in silico AMR prediction strategy missed some resistance identified by lab-based AST. In silico AMR prediction can therefore supplement lab-based AST, but cannot yet replace it.

  • Open Access

    Evaluation of the Antimicrobial Activity of a 3% Chlorhexidine/Ophytrium Mousse and Shampoo in 18 Healthy Dogs

    by Matt McHale, Sonya Bettenay, Gavin K. Paterson, Tim Nuttall, Victoria Robinson

    Background: Topical antimicrobial therapy is vital for managing pyoderma yet poor compliance can affect treatment outcomes. Hypothesis/Objective: To evaluate the antimicrobial activity of a 3% chlorhexidine/ophytrium shampoo at different contact times and the residual activity of a 3% chlorhexidine/ophytrium mousse against meticillin‐susceptible and ‐resistant Staphylococcus pseudintermedius (MSSP and MRSP), Escherichia coli (EC), ESBL‐producing E. coli (ESBL), Pseudomonas aeruginosa (PA), and Malassezia pachydermatis (MP) in vitro. Animals: 18 privately owned dogs. Materials and Methods: Dogs were treated once with the shampoo for 3, 5 and 10 min, with hair samples taken after rinsing. The mousse was applied once. Hair samples were collected at 30 min (Day [D]0) and at D2, D4, D7 and D14 post‐treatment. Hair bundles were plated on Mueller–Hinton (MH) agar plates pre‐inoculated with MSSP, MRSP, EC, ESBL and PA, and on supplemented MH plates pre‐inoculated with MP. Zones of inhibition (ZIs) were measured after 24 h (bacteria) and 48 h (MP) incubation. Results: Shampoo—there were no significant differences in antimicrobial activity between the contact times for any of the isolates. Mousse—for all the isolates, there was significant growth inhibition compared to the negative controls on D0, D2 and D4. Conclusions and Clinical Relevance: Hairs exposed to the shampoo and mousse inhibited growth of all the isolates in vitro. A 3 min contact time was noninferior to 10 min for the shampoo. The mousse showed residual activity for ≥ 4 days for MSSP, MRSP, EC, PA and MP.


  • Open Access

    Otitis media/interna and encephalitozoonosis are the most common causes of head tilt in pet rabbits in the UK: 73 cases (2009‒2020)

    by Theofanis Liatis, Nikoleta Makri, Michał Czopowicz, Jenna Richardson, Tim Nuttall, Anna Suñol

    Background: There are limited studies that identify diseases associated with head tilt in pet rabbits. Methods: This was an observational, retrospective, single‐centre study of rabbits with head tilt presented between 2009 and 2020. Descriptive statistics were performed for all cases, whereas univariate and multivariate analyses were only performed for the 36 cases with a final diagnosis. Results: Seventy‐three rabbits met the inclusion criteria. The final diagnoses included Encephalitozoon cuniculi meningoencephalomyelitis (EC) (15/36; 41.7%), otitis media/interna (OMI) (8/36; 22.2%) and concurrent EC and OMI (13/38; 36.1%). Subacute‐to‐chronic onset was more common in rabbits with OMI than in those with EC ( p = 0.018). Previous middle ear surgery ( p = 0.046) and a diagnosis of otitis externa ( p = 0.004) significantly increased the risk of OMI. Meloxicam was associated with improvement of clinical signs ( p = 0.007). Upright ears ( p = 0.013), recumbency ( p = 0.037) and impaired mentation ( p = 0.001) were associated with a higher risk of death/euthanasia. The proportions of residual head tilt (66.7%) and relapse of vestibular signs (42.1%) were high. Limitations: This was a retrospective study with cases varying in their investigation and conclusive final diagnoses. Conclusion: OMI and EC were the most common aetiologies of head tilt in pet rabbits in the UK. Meloxicam might be associated with a favourable outcome in affected rabbits. Paired EC serology and a CT scan of the head should be the baseline investigation for head tilt in rabbits.


  • Open Access

    Cytological evaluation, culture and genomics to evaluate the microbiome in healthy rabbit external ear canals

    by Nikoleta Makri, Natalie Ring, Darren J. Shaw, Athinodoros Athinodorou, Victoria Robinson, Gavin K. Paterson, Jenna Richardson, Debbie Gow, Tim Nuttall

    Background: Lop‐eared rabbits may be predisposed to otitis externa (OE) as a consequence of their ear conformation. Although otoscopy, otic cytological evaluation and culture are valuable tools in dogs and cats, published data on rabbits remain lacking.Hypothesis/Objectives: This study aimed to assess the utility of otoscopy and cytological results in evaluating healthy rabbit external ear canals (EECs) and to characterise ear cytological and microbiological findings through culture techniques and metagenomic sequencing.Animals: Sixty‐three otitis‐free client‐owned rabbits.Materials and Methods: All rabbits underwent otoscopy and ear cytological evaluation. In a subset of 12 rabbits, further bacterial and fungal culture, fungal DNA assessment and metagenomic sequencing were performed.Results: Otic cytological results revealed yeast in 73%, cocci in 42.9% and rods in 28.6% of healthy rabbit EECs. Compared to upright‐eared rabbits, lop‐eared rabbits had more discharge and more bacteria per oil immersion field. Culture isolated eight different species yet metagenomic sequencing identified 36, belonging to the Bacillota (Firmicutes), Pseudomonadota and Actinomycetota phyla. Staphylococcus were the most commonly observed species with both methods. Ten of 12 rabbits were yeast‐positive on cytological evaluation with only three yielding fungal growth identified as Yarrowia (Candida) lipolytica, Eurotium echinulatum and Cystofilobasidium infirmominiatum.Conclusions and Clinical Relevance: Healthy rabbit EECs lack inflammatory cells yet can host yeast and bacteria, emphasising the need to evaluate cytological results alongside the clinical signs. Lop‐ear anatomy may predispose to bacterial overgrowth and OE. Notably, yeasts may be present despite a negative culture.


  • Open Access

    Rapid metagenomic sequencing for diagnosis and antimicrobial sensitivity prediction of canine bacterial infections

    by Natalie Ring, Alison S. Low, Bryan Wee, Gavin K. Paterson, Tim Nuttall, David Gally, Richard Mellanby, J. Ross Fitzgerald

    Antimicrobial resistance is a major threat to human and animal health. There is an urgent need to ensure that antimicrobials are used appropriately to limit the emergence and impact of resistance. In the human and veterinary healthcare setting, traditional culture and antimicrobial sensitivity testing typically requires 48–72 h to identify appropriate antibiotics for treatment. In the meantime, broad-spectrum antimicrobials are often used, which may be ineffective or impact non-target commensal bacteria. Here, we present a rapid, culture-free, diagnostics pipeline, involving metagenomic nanopore sequencing directly from clinical urine and skin samples of dogs. We have planned this pipeline to be versatile and easily implementable in a clinical setting, with the potential for future adaptation to different sample types and animals. Using our approach, we can identify the bacterial pathogen present within 5 h, in some cases detecting species which are difficult to culture. For urine samples, we can predict antibiotic sensitivity with up to 95 % accuracy. Skin swabs usually have lower bacterial abundance and higher host DNA, confounding antibiotic sensitivity prediction; an additional host depletion step will likely be required during the processing of these, and other types of samples with high levels of host cell contamination. In summary, our pipeline represents an important step towards the design of individually tailored veterinary treatment plans on the same day as presentation, facilitating the effective use of antibiotics and promoting better antimicrobial stewardship.


  • Otitis

    by Tim Nuttall